Literature DB >> 19003527

Generation of novel chimeric LacdiNAcS by gene fusion of alpha-lactalbumin and beta1,4-galactosyltransferase 1.

Su-Il Do1.   

Abstract

Novel chimeric lacdiNAc (GalNAc(beta1-4)GlcNAc) synthase (c-LacdiNAcS) was generated by gene fusion of alpha-lactalbumin (alpha-LA) and beta1,4-galactosyltransferase 1 (beta1,4-GalT1). c-LacdiNAcS was expressed in Lec8 Chinese hamster ovary (Lec8 CHO) cells and exhibited N-acetylgalactosaminyltransferase (GalNAcT) activity in the absence of exogenous alpha-LA as well as other glycosyltransferase activities including lactose synthase (LacS), and beta1,4-GalT. These glycosyltransferase activities of c-LacdiNAcS were compared to those activities induced in LacS system under the co-presence of bovine beta1,4-GalT1 and alpha-LA, indicating that each domain of alpha-LA and beta1,4-GalT1 on c-LacdiNAcS is not only folding correctly, but also interacting together. Furthermore, c-LacdiNAcS was found to be auto-lacdiNAcylated and can synthesize lacdiNAc structures on cellular glycoproteins, demonstrating that GalNAcT activity of c-LacdiNAcS is functional in Lec8 CHO cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003527     DOI: 10.1007/s10719-008-9208-7

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  28 in total

1.  The macrophage/endothelial cell mannose receptor cDNA encodes a protein that binds oligosaccharides terminating with SO4-4-GalNAcbeta1,4GlcNAcbeta or Man at independent sites.

Authors:  D Fiete; M C Beranek; J U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Targeted mutation in beta1,4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality.

Authors:  Q Lu; P Hasty; B D Shur
Journal:  Dev Biol       Date:  1997-01-15       Impact factor: 3.582

3.  Crystal structures of the bovine beta4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose.

Authors:  L N Gastinel; C Cambillau; Y Bourne
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

4.  Human transferrin receptor contains O-linked oligosaccharides.

Authors:  S I Do; C Enns; R D Cummings
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

5.  Novel poly-GalNAcbeta1-4GlcNAc (LacdiNAc) and fucosylated poly-LacdiNAc N-glycans from mammalian cells expressing beta1,4-N-acetylgalactosaminyltransferase and alpha1,3-fucosyltransferase.

Authors:  Ziad S Kawar; Stuart M Haslam; Howard R Morris; Anne Dell; Richard D Cummings
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

6.  Molecular cloning and enzymatic characterization of a UDP-GalNAc:GlcNAc(beta)-R beta1,4-N-acetylgalactosaminyltransferase from Caenorhabditis elegans.

Authors:  Ziad S Kawar; Irma Van Die; Richard D Cummings
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

7.  Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities.

Authors:  A Dell; H R Morris; R L Easton; M Panico; M Patankar; S Oehniger; R Koistinen; H Koistinen; M Seppala; G F Clark
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

Review 8.  Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.

Authors:  A Kwame Nyame; Ziad S Kawar; Richard D Cummings
Journal:  Arch Biochem Biophys       Date:  2004-06-15       Impact factor: 4.013

9.  Demonstration of a novel UDPGalNAc:GlcNAc beta 1-4 N-acetylgalactosaminyltransferase in extracts of Schistosoma mansoni.

Authors:  J Srivatsan; D F Smith; R D Cummings
Journal:  J Parasitol       Date:  1994-12       Impact factor: 1.276

10.  Bovine mammary gland UDP-GalNAc:GlcNAcbeta-R beta1-->4-N-acetylgalactosaminyltransferase is glycoprotein hormone nonspecific and shows interaction with alpha-lactalbumin.

Authors:  I M Van den Nieuwenhof; W E Schiphorst; I Van Die; D H Van den Eijnden
Journal:  Glycobiology       Date:  1999-02       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.